JP2018526403A5 - - Google Patents

Download PDF

Info

Publication number
JP2018526403A5
JP2018526403A5 JP2018512407A JP2018512407A JP2018526403A5 JP 2018526403 A5 JP2018526403 A5 JP 2018526403A5 JP 2018512407 A JP2018512407 A JP 2018512407A JP 2018512407 A JP2018512407 A JP 2018512407A JP 2018526403 A5 JP2018526403 A5 JP 2018526403A5
Authority
JP
Japan
Prior art keywords
formulation
antibody
intestinal wall
item
penetrating member
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2018512407A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018526403A (ja
Filing date
Publication date
Priority claimed from US15/150,379 external-priority patent/US11548940B2/en
Application filed filed Critical
Priority claimed from PCT/US2016/050832 external-priority patent/WO2017044665A1/en
Publication of JP2018526403A publication Critical patent/JP2018526403A/ja
Publication of JP2018526403A5 publication Critical patent/JP2018526403A5/ja
Priority to JP2021125408A priority Critical patent/JP2021169530A/ja
Withdrawn legal-status Critical Current

Links

JP2018512407A 2015-09-08 2016-09-08 嚥下可能な薬物送達デバイスを使用する腸管の管腔中への送達のためのｐｃｓｋ９抗体製剤 Withdrawn JP2018526403A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021125408A JP2021169530A (ja) 2015-09-08 2021-07-30 嚥下可能な薬物送達デバイスを使用する腸管の管腔中への送達のためのｐｃｓｋ９抗体製剤

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562215586P 2015-09-08 2015-09-08
US62/215,586 2015-09-08
US15/150,379 2016-05-09
US15/150,379 US11548940B2 (en) 2014-05-15 2016-05-09 Anti-interleukin antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
PCT/US2016/050832 WO2017044665A1 (en) 2015-09-08 2016-09-08 Pcsk9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021125408A Division JP2021169530A (ja) 2015-09-08 2021-07-30 嚥下可能な薬物送達デバイスを使用する腸管の管腔中への送達のためのｐｃｓｋ９抗体製剤

Publications (2)

Publication Number Publication Date
JP2018526403A JP2018526403A (ja) 2018-09-13
JP2018526403A5 true JP2018526403A5 (cg-RX-API-DMAC7.html) 2019-10-03

Family

ID=58240088

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2018512407A Withdrawn JP2018526403A (ja) 2015-09-08 2016-09-08 嚥下可能な薬物送達デバイスを使用する腸管の管腔中への送達のためのｐｃｓｋ９抗体製剤
JP2021125408A Pending JP2021169530A (ja) 2015-09-08 2021-07-30 嚥下可能な薬物送達デバイスを使用する腸管の管腔中への送達のためのｐｃｓｋ９抗体製剤
JP2023084891A Pending JP2023104992A (ja) 2015-09-08 2023-05-23 嚥下可能な薬物送達デバイスを使用する腸管の管腔中への送達のためのｐｃｓｋ９抗体製剤

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2021125408A Pending JP2021169530A (ja) 2015-09-08 2021-07-30 嚥下可能な薬物送達デバイスを使用する腸管の管腔中への送達のためのｐｃｓｋ９抗体製剤
JP2023084891A Pending JP2023104992A (ja) 2015-09-08 2023-05-23 嚥下可能な薬物送達デバイスを使用する腸管の管腔中への送達のためのｐｃｓｋ９抗体製剤

Country Status (7)

Country Link
EP (1) EP3347050B1 (cg-RX-API-DMAC7.html)
JP (3) JP2018526403A (cg-RX-API-DMAC7.html)
CN (1) CN108401419A (cg-RX-API-DMAC7.html)
AU (2) AU2016320867B2 (cg-RX-API-DMAC7.html)
CA (1) CA2997958A1 (cg-RX-API-DMAC7.html)
DK (1) DK3347050T3 (cg-RX-API-DMAC7.html)
WO (1) WO2017044665A1 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10220076B2 (en) 2014-05-15 2019-03-05 Incube Labs, Llc Pharmaceutical compositions and methods for fabrication of solid masses comprising glucose regulating proteins
US10689460B2 (en) 2014-05-15 2020-06-23 Incube Labs, Llc PCSK9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US11207272B2 (en) 2017-05-17 2021-12-28 Massachusetts Institute Of Technology Tissue anchoring articles
US11541015B2 (en) 2017-05-17 2023-01-03 Massachusetts Institute Of Technology Self-righting systems, methods, and related components
AU2019269636A1 (en) 2018-05-17 2020-11-19 Massachusetts Institute Of Technology Systems for electrical stimulation
US12128133B2 (en) 2018-09-25 2024-10-29 Rani Therapeutics, Llc Ingestible device with expandable enclosure
US20200206132A1 (en) * 2018-12-31 2020-07-02 Incube Labs, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
EP3917598B1 (en) 2019-02-01 2025-10-29 Massachusetts Institute of Technology Systems for liquid injection
KR20220004148A (ko) * 2019-05-03 2022-01-11 라니 테라퓨틱스, 엘엘씨 삼킬 수 있는 약물 전달 장치를 사용하여 장관 조직으로 전달하기 위한 응고인자 제제
US11541216B2 (en) 2019-11-21 2023-01-03 Massachusetts Institute Of Technology Methods for manufacturing tissue interfacing components

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102905753B (zh) * 2009-12-24 2016-06-29 因卡伯实验室有限责任公司 可吞咽式药剂递送装置和药剂递送方法
US8759284B2 (en) * 2009-12-24 2014-06-24 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9149617B2 (en) * 2010-12-23 2015-10-06 Rani Therapeutics, Llc Device, system and methods for the oral delivery of therapeutic compounds
PL2726091T3 (pl) * 2011-06-29 2020-08-10 Rani Therapeutics, Llc Preparaty lecznicze dostarczane do kanału przewodu jelitowego za pomocą połykalnego urządzenia dostarczającego lek
EP3653223B1 (en) * 2011-06-29 2021-08-25 Rani Therapeutics, LLC Device for the oral delivery of therapeutic compounds
BR112014000392A2 (pt) * 2011-07-14 2017-02-21 Pfizer tratamento com anticorpos anti-pcsk9
EA201691320A1 (ru) * 2014-02-14 2016-11-30 Ридженерон Фармасьютикалз, Инк. Способы лечения пациентов с гиперхолестеринемией, которая устойчива к терапии умеренными дозами статинов
EP3294273A4 (en) * 2015-05-08 2018-12-05 Incube Labs, LLC Anti-interleukin antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

Similar Documents

Publication Publication Date Title
JP2018526403A5 (cg-RX-API-DMAC7.html)
AU2020256337B2 (en) Dosing regimens for echinocandin class compounds
JP5749255B2 (ja) Ｌ−オルニチンフェニル酢酸塩を用いる門脈圧亢進の治療及び肝機能の修復
JP4489356B2 (ja) 浸透促進剤
AU718971C (en) Colonic delivery of nicotine to treat inflammatory bowel disease
EP3316873B1 (en) Device for oral delivery of active agents
JP2005506367A5 (cg-RX-API-DMAC7.html)
US20070292512A1 (en) Solid Oral Dosage Form Containing an Enhancer
JP2018519313A5 (cg-RX-API-DMAC7.html)
Singh et al. Pulsatile drug delivery system: an approach of medication according to circadian rhythm
CN101277684A (zh) 至少一种活性成分改善释放的微粒及含有该微粒的口服药物剂型
US20110218246A1 (en) Methods of treating non-nociceptive pain states with gastric retentive gabapentin
JP2022524446A5 (cg-RX-API-DMAC7.html)
JP2023120445A (ja) テルリプレシン組成物およびその使用方法
JP2005528430A5 (cg-RX-API-DMAC7.html)
Gupta et al. Old drugs, new delivery systems in Parkinson’s disease
WO2021145436A1 (ja) 目的とする既知の薬剤又はその等価物質の新たな適応症の予測方法、予測装置、及び予測プログラム
JP2016530279A (ja) 新規２，４−ジニトロフェノール製剤およびその使用法
JP2018520995A5 (cg-RX-API-DMAC7.html)
NZ787785A (en) Delayed release deferiprone tablets and methods of using the same
CN104379138B (zh) 阿坎酸制剂、其使用方法及包含阿坎酸制剂的组合
WO2014176417A1 (en) Topical preparation for bypassing gi tract, delivery of therapeutics, and trans-epithelial drug delivery system
JP2019517490A (ja) がん療法のためのメトロノミック経口ゲムシタビン
JP4370054B2 (ja) 腸粘膜傷害の予防及び治療剤
Pandey et al. Innovative approaches in HELICOBACTER pylori therapy: Clinical trials and advancements in Gastro-Retentive drug delivery systems